Viewing Study NCT06524466


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-09 @ 9:35 AM
Study NCT ID: NCT06524466
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-29
First Post: 2024-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module